07:00 , Apr 8, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Liver cancer Chromodomain helicase DNA binding protein 1-like (CHD1L) In vitro and mouse studies suggest that inhibiting CHD1L could help treat hepatocellular carcinoma (HCC). In...